Understanding the beneficial effects of iPSC therapy related with the suppression of NF-κB/NKRF signaling pathway and inflammatory responses may allow clarification of the biomolecular mechanisms regulating VILI and provide insight into novel therapeutic option for ALI/ARDS. The gene discussed is NKRF; the disease is acute respiratory distress syndrome.